Natalia (Natasha) Shilnikova, MD, PhD

Risk Analyst 3, Senior Epidemiologist

Dr. Shilnikova is a Senior Health Risk Analyst with RSI. She has extensive experience in the study of cancer and radiation epidemiology, and systematic reviews of literature for toxicological evaluation.

Dr. Shilnikova regularly serves as a key team member on several RSI projects involving toxicity, epidemiology, and human health risk assessment. Dr. Shilnikova has previously been involved in a systematic review of potential cancer and reproductive risks of artificial sweeteners for the International Prevention Research Institute (IPRI) of Lyon, France; a comprehensive review of the literature related to the human health effects of manganese, and research and development of toxicity profiles for several chemicals on Health Canada’s Domestic Substances List (DSL).